Höffken HW - Search Results

1

Structure determination of seven phases and solvates of Pigment Yellow 183 and Pigment Yellow 191 from X-ray powder and single-crystal data.

Ivashevskaya SN, van de Streek J, Djanhan JE, Brüning J, Alig E, Bolte M, Schmidt MU, Blaschka P, Höffken HW, Erk P. Ivashevskaya SN, et al. Among authors: hoffken hw. Acta Crystallogr B. 2009 Apr;65(Pt 2):212-22. doi: 10.1107/S0108768109001827. Epub 2009 Mar 16. Acta Crystallogr B. 2009. PMID: 19299877

2

Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.

Mack H, Pfeiffer T, Hornberger W, Böhm HJ, Höffken HW. Mack H, et al. Among authors: hoffken hw. J Enzyme Inhib. 1995;9(1):73-86. doi: 10.3109/14756369509040682. J Enzyme Inhib. 1995. PMID: 8568568

3

D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.

Lange UE, Baucke D, Hornberger W, Mack H, Seitz W, Höffken HW. Lange UE, et al. Among authors: hoffken hw. Bioorg Med Chem Lett. 2003 Jun 16;13(12):2029-33. doi: 10.1016/s0960-894x(03)00347-0. Bioorg Med Chem Lett. 2003. PMID: 12781189

4

Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety.

Lange UE, Baucke D, Hornberger W, Mack H, Seitz W, Höffken HW. Lange UE, et al. Among authors: hoffken hw. Bioorg Med Chem Lett. 2006 May 15;16(10):2648-53. doi: 10.1016/j.bmcl.2006.01.046. Epub 2006 Feb 3. Bioorg Med Chem Lett. 2006. PMID: 16460939

5

Orally active thrombin inhibitors. Part 1: optimization of the P1-moiety.

Mack H, Baucke D, Hornberger W, Lange UE, Seitz W, Höffken HW. Mack H, et al. Among authors: hoffken hw. Bioorg Med Chem Lett. 2006 May 15;16(10):2641-7. doi: 10.1016/j.bmcl.2006.02.040. Epub 2006 Mar 6. Bioorg Med Chem Lett. 2006. PMID: 16517159

6

A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus.

Friedrich T, Kröger B, Bialojan S, Lemaire HG, Höffken HW, Reuschenbach P, Otte M, Dodt J. Friedrich T, et al. Among authors: hoffken hw. J Biol Chem. 1993 Aug 5;268(22):16216-22. J Biol Chem. 1993. PMID: 8344906 Free article.

7

A single point mutation enhances hydroxynitrile synthesis by halohydrin dehalogenase.

Schallmey M, Jekel P, Tang L, Majerić Elenkov M, Höffken HW, Hauer B, Janssen DB. Schallmey M, et al. Among authors: hoffken hw. Enzyme Microb Technol. 2015 Mar;70:50-7. doi: 10.1016/j.enzmictec.2014.12.009. Epub 2014 Dec 24. Enzyme Microb Technol. 2015. PMID: 25659632

8

Inhibitors of the herbicidal target IspD: allosteric site binding.

Witschel MC, Höffken HW, Seet M, Parra L, Mietzner T, Thater F, Niggeweg R, Röhl F, Illarionov B, Rohdich F, Kaiser J, Fischer M, Bacher A, Diederich F. Witschel MC, et al. Among authors: hoffken hw. Angew Chem Int Ed Engl. 2011 Aug 16;50(34):7931-5. doi: 10.1002/anie.201102281. Epub 2011 Jul 18. Angew Chem Int Ed Engl. 2011. PMID: 21766403 No abstract available.

9

Crystal structure and enzyme kinetics of the (S)-specific 1-phenylethanol dehydrogenase of the denitrifying bacterium strain EbN1.

Höffken HW, Duong M, Friedrich T, Breuer M, Hauer B, Reinhardt R, Rabus R, Heider J. Höffken HW, et al. Biochemistry. 2006 Jan 10;45(1):82-93. doi: 10.1021/bi051596b. Biochemistry. 2006. PMID: 16388583

10

Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD.

Kunfermann A, Witschel M, Illarionov B, Martin R, Rottmann M, Höffken HW, Seet M, Eisenreich W, Knölker HJ, Fischer M, Bacher A, Groll M, Diederich F. Kunfermann A, et al. Among authors: hoffken hw. Angew Chem Int Ed Engl. 2014 Feb 17;53(8):2235-9. doi: 10.1002/anie.201309557. Epub 2014 Jan 20. Angew Chem Int Ed Engl. 2014. PMID: 24446431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page